Pharmaceutical Information |
Drug Name |
Antivenin (micrurus fulvius) |
Drug ID |
BADD_D00150 |
Description |
North American Coral Snake Antivenin (Equine) is a horse-derived antivenin indicated for the treatment of envenomation caused by North American coral snake bites. It is intravenously administered so that the antivenin binds to and neutralizes coral snake venom.
The antivenin is a refined, concentrated, and lyophilized preparation of serum globulins obtained by fractionating blood from healthy horses that have been immunized with eastern coral snake (Micrurus fulvius fulvius) venom [FDA Label]. Prior to lyophilization, the product contains 0.25% phenol and 0.005% thiomerosal (mercury derivative) [FDA Label]. |
Indications and Usage |
This particular antivenin is indicated only for the treatment of envenomation caused by bites from Eastern coral snakes (Micrurus fulvius fulvius) and Texas coral snakes (Micrurus fulvius tenere) [FDA Label, L2176]. The agent will not neutralize the venom of Arizona (Sonoran) coral snakes (Micruroides euryxanthus) or that of South American species [FDA Label, L2176]. |
Marketing Status |
approved; experimental |
ATC Code |
Not Available |
DrugBank ID |
DB13883
|
KEGG ID |
D02962; D02961; D02963
|
MeSH ID |
D000997
|
PubChem ID |
Not Available
|
TTD Drug ID |
Not Available
|
NDC Product Code |
0008-0423 |
UNII |
Not Available
|
Synonyms |
Antivenins | Anti-Venoms | Anti Venoms | Anti-Venin | Anti Venin | Anti-Venins | Anti Venins | Anti-Venom | Anti Venom | Antivenin | Antivenom | Antivenoms |
|
Chemical Information |
Molecular Formula |
Not Available |
CAS Registry Number |
Not Available |
SMILES |
Not Available |
Chemical Structure |
|
|
ADRs Induced by Drug |
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|